Zhongren X. Ding

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Platelet RIP2 Limits Dense Granule Release and Thrombosis via DOCK8-Cdc42.

Platelet RIP2 Limits Dense Granule Release and Thrombosis via DOCK8-Cdc42.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 11, 2026

Ursodeoxycholic acid attenuates sepsis-associated platelet dysfunction through TREM2-linked signaling.

Ursodeoxycholic acid attenuates sepsis-associated platelet dysfunction through TREM2-linked signaling.

Journal: International immunopharmacology

Published: April 19, 2026

Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis.

Exosome-mediated transfer of NOD2 from platelets to monocytes: a novel therapeutic target for atherosclerosis.

Journal: Biochemical pharmacology

Published: March 31, 2026

A novel noncanonical Src-mammalian STE20-like kinase 1 (MST1)-Akt/glycogen synthase kinase-3β (GSK3β) pathway drives platelet activation and thrombosis.

A novel noncanonical Src-mammalian STE20-like kinase 1 (MST1)-Akt/glycogen synthase kinase-3β (GSK3β) pathway drives platelet activation and thrombosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 14, 2026

Rab31 promotes platelet activation and arterial thrombosis via ERK-PLCβ3 signaling and regulation of CD151.

Rab31 promotes platelet activation and arterial thrombosis via ERK-PLCβ3 signaling and regulation of CD151.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 23, 2026

Ursodeoxycholic acid inhibits platelet activation and thrombosis via TREM2: Evidence from mouse models and human studies.

Ursodeoxycholic acid inhibits platelet activation and thrombosis via TREM2: Evidence from mouse models and human studies.

Journal: British journal of pharmacology

Published: November 13, 2025

Treatment approaches for affected eyes in hospitalized patients with acute primary angle-closure glaucoma: a multicenter retrospective analysis

Treatment approaches for affected eyes in hospitalized patients with acute primary angle-closure glaucoma: a multicenter retrospective analysis

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: September 08, 2025

Tyrphostin AG538 inhibits platelet activation and thrombosis via TREM2 agonism.

Tyrphostin AG538 inhibits platelet activation and thrombosis via TREM2 agonism.

Journal: Biochemical pharmacology

Published: July 07, 2025

Endoplasmic Reticulum Stress-Induced triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Downregulation Exacerbates Platelet Activation and Myocardial Infarction in Patients With Coronary Artery Disease.

Endoplasmic Reticulum Stress-Induced triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Downregulation Exacerbates Platelet Activation and Myocardial Infarction in Patients With Coronary Artery Disease.

Journal: Journal of the American Heart Association

Published: June 24, 2025

Rare VPS33B gene mutation combined with GP1BA mutation causes severe decrease in plasma VWF levels: a case report and literature review

Rare VPS33B gene mutation combined with GP1BA mutation causes severe decrease in plasma VWF levels: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: August 12, 2024

Genomic-transcriptomic analysis identifies the Syrian hamster as a superior animal model for human diseases.

Genomic-transcriptomic analysis identifies the Syrian hamster as a superior animal model for human diseases.

Journal: BMC genomics

Published: February 16, 2024

Endothelial YAP Mediates Hyperglycemia-Induced Platelet Hyperactivity and Arterial Thrombosis.

Endothelial YAP Mediates Hyperglycemia-Induced Platelet Hyperactivity and Arterial Thrombosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: November 02, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026